Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease — Carol A. Pollock (2017) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease
Shared by
Giuseppe Remuzzi
The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease
Article
2017
en
Authors
+12 more
CP
Carol A. Pollock
AŻ
Anna Żuk
HA
Hans‐Joachim Anders
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2016
Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease
Peter J Barnes
Editorial Material
1998
Novel strategies to retard renal disease progression: combining ACE inhibition with endothelin receptor blocking?
Ariela Benigni
,
Giuseppe Remuzzi
Article
2006
Progression of chronic kidney disease: insights from animal models
Carla Zoja
,
Mauro Abbate
,
Giuseppe Remuzzi
Preprint
2023
Ultrasonographically determined kidney volume and progression to end-stage kidney disease in pediatric chronic kidney disease: data from the KNOW-Ped CKD study
Ji Hyun Kim
,
Yo Han Ahn
,
Eun Mi Yang
,
Eujin Park
,
Ji Yeon Song
,
Hee Sun Baek
,
Jeong Yeon Kim
,
Keum Hwa Lee
,
Jae Il Shin
,
Heeyeon Cho
,
Jiwon Jung
,
Joo Hoon Lee
,
Young Seo Park
,
Il Soo Ha
,
Hee Gyung Gang
,
Min Hyun Cho
,
Kyoung Hee Han
Article
2006
Chemokine receptors as therapeutic targets in chronic obstructive pulmonary disease
Louise Donnelly
,
Peter J Barnes
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.